Positive pre-clinical proof of concept in MS fatigue model
Chronos announces positive pre-clinical results for the lead compound in its DAT inhibitor programme in an in vivo model of fatigue in multiple sclerosis (MS). Read the press release.
Positive pre-clinical proof of concept studies in orexin-1 antagonist project
Chronos has demonstrated positive pre-clinical proof of concept (POC) results for the lead compound in its orexin-1 antagonist programme in an in vivo model of binge eating disorder (BED). Read [...]